{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:16:00Z","timestamp":1793330160743,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The effectiveness of intravenous immunoglobulin (IVIg) for patients with unexplained recurrent implantation failure (uRIF) remains debated. We retrospectively analysed outcomes of uRIF patients treated with IVIg compared to a separate control uRIF cohort within our center (01\/2014\u201312\/2021). Primary outcomes included live birth, miscarriage, or transfer failure. We documented IVIg side effects and maternal\/fetal outcomes. Logistic regression analysis was used to assess for association of IVIg exposure with outcomes and adjust for confounders. The study included 143 patients, with a 2:1 ratio of controls to patients receiving IVIg treatment. Patient characteristics were similar between groups. There was higher live birth rate (LBR) in patients receiving IVIg (32\/49; 65.3%) compared to controls (32\/94; 34%); p\u2009&lt;\u20090.001). When stratifying patients into moderate and severe uRIF (respectively 3\u20134 and\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\ge$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mo>\u2265<\/mml:mo>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    5 previous good quality blastocyst transfer failures), only patients with severe uRIF benefited from IVIg (LBR (20\/29 (69%) versus 5\/25 (20%) for controls, p\u2009=\u20090.0004). In the logistic regression analysis, IVIg was associated with higher odds of live birth (OR 3.64; 95% CI 1.78\u20137.67; p\u2009=\u20090.0004). There were no serious adverse events with IVIg. IVIg can be considered in well selected patients with\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\ge$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mo>\u2265<\/mml:mo>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    5 previous unexplained, high quality blastocyst transfer failures. A randomized controlled trial is needed to confirm these findings.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-54423-z","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T05:02:51Z","timestamp":1708059771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes"],"prefix":"10.1038","volume":"14","author":[{"given":"Einav Kadour","family":"Peero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorooq","family":"Banjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Khoudja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaonie","family":"Ton-leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Beauchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Beltempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Jacques","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Laskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Mahutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauna","family":"Reinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Buckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"5","key":"54423_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.rbmo.2020.08.007","volume":"41","author":"T Shaulov","year":"2020","unstructured":"Shaulov, T., Sierra, S. & Sylvestre, C. Recurrent implantation failure in IVF: A Canadian fertility and andrology society clinical practice guideline. Reprod. Biomed. Online 41(5), 819\u2013833 (2020).","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"54423_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-018-0414-2","volume":"16","author":"A Bashiri","year":"2018","unstructured":"Bashiri, A., Halper, K. I. & Orvieto, R. Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions. Reprod. Biol. Endocrinol. 16(1), 121 (2018).","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"54423_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.fertnstert.2023.02.014","volume":"120","author":"P Pirtea","year":"2023","unstructured":"for the participants to the Lugano RIFW et al. Recurrent implantation failure: Reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure. Fertil. Steril. 120(1), 45\u201359 (2023).","journal-title":"Fertil. Steril."},{"issue":"10","key":"54423_CR4","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/humrep\/dez120","volume":"34","author":"YEM Koot","year":"2019","unstructured":"Koot, Y. E. M. et al. What is the prognosis for a live birth after unexplained recurrent implantation failure following IVF\/ICSI?. Hum. Reprod. 34(10), 2044\u20132052 (2019).","journal-title":"Hum. Reprod."},{"issue":"1","key":"54423_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.fertnstert.2020.07.002","volume":"115","author":"P Pirtea","year":"2021","unstructured":"Pirtea, P. et al. Rate of true recurrent implantation failure is low: Results of three successive frozen euploid single embryo transfers. Fertil. Steril. 115(1), 45\u201353 (2021).","journal-title":"Fertil. Steril."},{"issue":"3","key":"54423_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00404-020-05775-0","volume":"304","author":"M Cozzolino","year":"2021","unstructured":"Cozzolino, M. Recurrent implantation failure might be overestimated without PGT-A. Arch. Gynecol. Obstet. 304(3), 849\u2013850 (2021).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"54423_CR7","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1530\/REP-22-0150","volume":"165","author":"G Genest","year":"2023","unstructured":"Genest, G. et al. Immunomodulation for unexplained recurrent implantation failure: Where are we now?. Reproduction 165(2), R39\u2013R60 (2023).","journal-title":"Reproduction"},{"issue":"7","key":"54423_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/humrep\/dev098","volume":"30","author":"A Moffett","year":"2015","unstructured":"Moffett, A. & Shreeve, N. First do no harm: Uterine natural killer (NK) cells in assisted reproduction. Hum. Reprod. 30(7), 1519\u20131525 (2015).","journal-title":"Hum. Reprod."},{"issue":"2","key":"54423_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.gendis.2019.03.005","volume":"7","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. The number and cytotoxicity and the expression of cytotoxicity-related molecules in peripheral natural killer (NK) cells do not predict the repeated implantation failure (RIF) for the in vitro fertilization patients. Genes Dis. 7(2), 283\u2013289 (2020).","journal-title":"Genes Dis."},{"issue":"5","key":"54423_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/humrep\/deh774","volume":"20","author":"MY Thum","year":"2005","unstructured":"Thum, M. Y. et al. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum. Reprod. 20(5), 1272\u20131276 (2005).","journal-title":"Hum. Reprod."},{"issue":"3","key":"54423_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11845-018-1933-8","volume":"188","author":"C Harrity","year":"2019","unstructured":"Harrity, C., Bereir, M. M., Walsh, D. J. & Marron, K. D. Moving from peripheral blood to local uterine immunophenotype analysis in patients with poor reproductive history: Pilot study of a novel technique. Ir. J. Med. Sci. 188(3), 893\u2013901 (2019).","journal-title":"Ir. J. Med. Sci."},{"key":"54423_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fimmu.2020.01032","volume":"11","author":"N Ledee","year":"2020","unstructured":"Ledee, N. et al. Endometrial immune profiling: A method to design personalized care in assisted reproductive medicine. Front. Immunol. 11, 1032 (2020).","journal-title":"Front. Immunol."},{"key":"54423_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jri.2016.11.007","volume":"119","author":"N Ledee","year":"2017","unstructured":"Ledee, N. et al. Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study. J. Reprod. Immunol. 119, 23\u201330 (2017).","journal-title":"J. Reprod. Immunol."},{"issue":"21","key":"54423_CR14","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMra1009433","volume":"367","author":"EW Gelfand","year":"2012","unstructured":"Gelfand, E. W. Intravenous immune globulin in autoimmune and inflammatory diseases. N. Engl. J. Med. 367(21), 2015\u20132025 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"54423_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.anai.2012.04.014","volume":"108","author":"KA Brinker","year":"2012","unstructured":"Brinker, K. A. & Silk, H. J. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy. Ann. Allergy Asthma Immunol. 108(6), 464\u2013465 (2012).","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4","key":"54423_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jceh.2013.10.004","volume":"3","author":"AG Feldman","year":"2013","unstructured":"Feldman, A. G. & Whitington, P. F. Neonatal hemochromatosis. J. Clin. Exp. Hepatol. 3(4), 313\u2013320 (2013).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"6","key":"54423_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaip.2023.04.002","volume":"11","author":"J Bayry","year":"2023","unstructured":"Bayry, J. et al. Intravenous immunoglobulin: Mechanism of action in autoimmune and inflammatory conditions. J. Allergy Clin. Immunol. Pract. 11(6), 1688\u20131697 (2023).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"54423_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.neurol.2021.10.004","volume":"178","author":"E N'Kaoua","year":"2022","unstructured":"N\u2019Kaoua, E. et al. Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre. Rev. Neurol. (Paris) 178(6), 616\u2013623 (2022).","journal-title":"Rev. Neurol. (Paris)"},{"issue":"6","key":"54423_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/aji.12170","volume":"70","author":"J Li","year":"2013","unstructured":"Li, J., Chen, Y., Liu, C., Hu, Y. & Li, L. Intravenous immunoglobulin treatment for repeated IVF\/ICSI failure and unexplained infertility: A systematic review and a meta-analysis. Am. J. Reprod. Immunol. 70(6), 434\u2013447 (2013).","journal-title":"Am. J. Reprod. Immunol."},{"key":"54423_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jri.2019.07.006","volume":"134\u2013135","author":"S Abdolmohammadi-Vahid","year":"2019","unstructured":"Abdolmohammadi-Vahid, S. et al. The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis. J. Reprod. Immunol. 134\u2013135, 28\u201333 (2019).","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"54423_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13395","volume":"85","author":"W Saab","year":"2021","unstructured":"Saab, W. et al. A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses. Am. J. Reprod. Immunol. 85(4), e13395 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"54423_CR22","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41598-021-81439-6","volume":"11","author":"A Busnelli","year":"2021","unstructured":"Busnelli, A., Somigliana, E., Cirillo, F., Baggiani, A. & Levi-Setti, P. E. Efficacy of therapies and interventions for repeated embryo implantation failure: A systematic review and meta-analysis. Sci. Rep. 11(1), 1747 (2021).","journal-title":"Sci. Rep."},{"key":"54423_CR23","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.fertnstert.2014.08.029","volume":"102","author":"KM Nyborg","year":"2014","unstructured":"Nyborg, K. M., Kolte, A. M., Larsen, E. C. & Christiansen, O. B. Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization\/intracytoplasmic sperm injection. Fertil. Steril. 102, 1650-1655.e1 (2014).","journal-title":"Fertil. Steril."},{"issue":"5","key":"54423_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/aji.12217","volume":"71","author":"R Ramos-Medina","year":"2014","unstructured":"Ramos-Medina, R. et al. Experience in ivi g therapy for selected women with recurrent reproductive failure and nk cell expansion. Am. J. Reprod. Immunol. 71(5), 458\u201366 (2014).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"54423_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","volume":"68","author":"M Moraru","year":"2012","unstructured":"Moraru, M. et al. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. Am. J. Reprod. Immunol. 68(1), 75\u201384 (2012).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"54423_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1600-0897.2009.00790.x","volume":"63","author":"L Heilmann","year":"2010","unstructured":"Heilmann, L., Schorsch, M. & Hahn, T. CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF\/ICSI failure after additional IVIG-treatment. Am. J. Reprod. Immunol. 63(3), 263\u2013265 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"54423_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0015-0282(00)01622-8","volume":"74","author":"MD Stephenson","year":"2000","unstructured":"Stephenson, M. D. & Fluker, M. R. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: A randomized, placebo-controlled Canadian trial. Fertil. Steril. 74(6), 1108\u20131113 (2000).","journal-title":"Fertil. Steril."},{"issue":"2","key":"54423_CR28","first-page":"90","volume":"4","author":"CB Coulam","year":"2000","unstructured":"Coulam, C. B. & Goodman, C. Increased pregnancy rates after IVF\/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells. Early Pregnancy 4(2), 90\u201398 (2000).","journal-title":"Early Pregnancy"},{"issue":"1","key":"54423_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1749-6632.1994.tb21751.x","volume":"734","author":"G De Placido","year":"1994","unstructured":"De Placido, G. et al. Intravenous immunoglobulin (IVIG) in the prevention of implantation failures. Ann. N. Y. Acad. Sci. 734(1), 232\u2013234 (1994).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"54423_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.imlet.2015.12.010","volume":"176","author":"VP Chernyshov","year":"2016","unstructured":"Chernyshov, V. P., Dons\u2019koi, B. V., Sudoma, I. O. & Goncharova, Y. O. Multiple immune deviations predictive for IVF failure as possible markers for IVIG therapy. Immunol. Lett. 176, 44\u201350 (2016).","journal-title":"Immunol. Lett."},{"issue":"6","key":"54423_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","volume":"63","author":"M Ahmadi","year":"2017","unstructured":"Ahmadi, M. et al. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment. Syst. Biol. Reprod. Med. 63(6), 350\u2013359 (2017).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"54423_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3389\/fendo.2019.00937","volume":"10","author":"YK Ho","year":"2019","unstructured":"Ho, Y. K. et al. Peripheral CD56(+)CD16(+) NK cell populations in the early follicular phase are associated with successful clinical outcomes of intravenous immunoglobulin treatment in women with repeated implantation failure. Front. Endocrinol. (Lausanne) 10, 937 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"54423_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","volume":"129","author":"R Rachid","year":"2012","unstructured":"Rachid, R. & Bonilla, F. A. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: A comprehensive review of the literature. J. Allergy Clin. Immunol. 129(3), 628\u2013634 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"54423_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2017.44.1.1","volume":"44","author":"N Sung","year":"2017","unstructured":"Sung, N. et al. Intravenous immunoglobulin G in women with reproductive failure: The Korean society for reproductive immunology practice guidelines. Clin. Exp. Reprod. Med. 44(1), 1\u20137 (2017).","journal-title":"Clin. Exp. Reprod. Med."},{"key":"54423_CR35","doi-asserted-by":"publisher","first-page":"103189","DOI":"10.1016\/j.jri.2020.103189","volume":"142","author":"EV Woon","year":"2020","unstructured":"Woon, E. V., Day, A., Bracewell-Milnes, T., Male, V. & Johnson, M. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels\/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis. J. Reprod. Immunol. 142, 103189 (2020).","journal-title":"J. Reprod. Immunol."},{"key":"54423_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.biopha.2017.06.001","volume":"92","author":"M Ahmadi","year":"2017","unstructured":"Ahmadi, M. et al. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomed. Pharmacother. 92, 1095\u20131102 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"54423_CR37","doi-asserted-by":"publisher","first-page":"619437","DOI":"10.3389\/fendo.2021.619437","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y., Zhang, Y., Ma, X., Jia, W. & Su, Y. Determining diagnostic criteria of unexplained recurrent implantation failure: A retrospective study of two vs three or more implantation failure. Front. Endocrinol. (Lausanne). 12, 619437 (2021).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"6","key":"54423_CR38","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.jaci.2012.02.050","volume":"129","author":"AH Massoud","year":"2012","unstructured":"Massoud, A. H. et al. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells. J. Allergy Clin. Immunol. 129(6), 1656-65e3 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"54423_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1365-2222.2010.03663.x","volume":"41","author":"GN Kaufman","year":"2011","unstructured":"Kaufman, G. N. et al. Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma. Clin. Exp. Allergy 41(5), 718\u2013728 (2011).","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"54423_CR40","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/humrep\/deaa326","volume":"36","author":"AM Kolte","year":"2021","unstructured":"Kolte, A. M., Westergaard, D., Lidegaard, O., Brunak, S. & Nielsen, H. S. Chance of live birth: A nationwide, registry-based cohort study. Hum. Reprod. 36(4), 1065\u20131073 (2021).","journal-title":"Hum. Reprod."},{"issue":"2","key":"54423_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13737","volume":"90","author":"S Banjar","year":"2023","unstructured":"Banjar, S. et al. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss. Am. J. Reprod. Immunol. 90(2), e13737 (2023).","journal-title":"Am. J. Reprod. Immunol."},{"key":"54423_CR42","doi-asserted-by":"publisher","first-page":"101527","DOI":"10.1016\/j.eclinm.2022.101527","volume":"50","author":"H Yamada","year":"2022","unstructured":"Yamada, H. et al. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial. EClinicalMedicine 50, 101527 (2022).","journal-title":"EClinicalMedicine"},{"issue":"4","key":"54423_CR43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/humrep\/deab014","volume":"36","author":"D Cimadomo","year":"2021","unstructured":"Cimadomo, D. et al. Leave the past behind: women\u2019s reproductive history shows no association with blastocysts\u2019 euploidy and limited association with live birth rates after euploid embryo transfers. Hum. Reprod. 36(4), 929\u2013940 (2021).","journal-title":"Hum. Reprod."},{"issue":"6","key":"54423_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.fertnstert.2019.07.1346","volume":"112","author":"S Munne","year":"2019","unstructured":"Munne, S. et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: A multicenter randomized clinical trial. Fertil. Steril. 112(6), 1071-9e7 (2019).","journal-title":"Fertil. Steril."},{"issue":"22","key":"54423_CR45","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1056\/NEJMoa2103613","volume":"385","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. Live birth with or without preimplantation genetic testing for aneuploidy. N. Engl. J. Med. 385(22), 2047\u20132058 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"54423_CR46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1517\/14740338.2010.484419","volume":"9","author":"JB Caress","year":"2010","unstructured":"Caress, J. B., Kennedy, B. L. & Eickman, K. D. Safety of intravenous immunoglobulin treatment. Expert Opin. Drug Saf. 9(6), 971\u2013979 (2010).","journal-title":"Expert Opin. Drug Saf."},{"key":"54423_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13223-019-0393-7","volume":"15","author":"RM Gorczynski","year":"2019","unstructured":"Gorczynski, R. M., Maqbool, T. & Hoffmann, G. Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory network. Allergy Asthma Clin. Immunol. 15, 79 (2019).","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"2","key":"54423_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/aji.12289","volume":"72","author":"K Racicot","year":"2014","unstructured":"Racicot, K., Kwon, J. Y., Aldo, P., Silasi, M. & Mor, G. Understanding the complexity of the immune system during pregnancy. Am. J. Reprod. Immunol. 72(2), 107\u2013116 (2014).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"54423_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1095\/biolreprod.116.138438","volume":"95","author":"J Tanaka","year":"2016","unstructured":"Tanaka, J. et al. Intravenous immunoglobulin suppresses abortion relates to an increase in the CD44bright NK subset in recurrent pregnancy loss model mice. Biol. Reprod. 95(2), 37 (2016).","journal-title":"Biol. Reprod."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54423-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T08:11:46Z","timestamp":1708330306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54423-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54423"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-54423-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"14 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3876"}}